Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. reports news around its U.S. healthcare business, combining Humana insurance services with CenterWell healthcare services. Company updates commonly address Medicare Advantage and other health plan membership, Insurance segment benefit ratios, GAAP and adjusted earnings, full-year guidance, and capital returns through quarterly dividends.
News also covers CenterWell's senior-focused primary care, home health, pharmacy, hospice and retail pharmacy activities; prescription access and home delivery partnerships; healthcare research tied to medication adherence and chronic disease care; palliative care arrangements; health data interoperability; and board refreshment or other governance actions.
Humana Inc. (NYSE: HUM) announced a mid-term Adjusted EPS target of $37.00 for FY 2025, indicating a 14% annual growth from the updated FY 2022 outlook. The company raised its FY 2022 GAAP EPS guidance to approximately $23.08 and Adjusted EPS to approximately $25.00, reflecting a 21% increase from FY 2021. This growth is attributed to favorable medical cost trends in Medicare Advantage and the absence of expected COVID-19 disruptions. Humana continues to emphasize operational efficiencies and capital deployment for sustained earnings growth.
Humana Inc. (NYSE: HUM) has elected Brad D. Smith, former Executive Chairman and CEO of Intuit, to its Board of Directors. Smith, currently the President of Marshall University, has a strong track record of transforming companies, including nearly doubling Intuit's revenue during his leadership. Humana's Chairman, Kurt J. Hilzinger, expressed confidence in Smith's ability to drive growth and operational efficiencies in Humana's Medicare Advantage business and enhance its healthcare services. With Smith's addition, Humana's Board now comprises 14 members.
Humana Inc. (NYSE: HUM) will host a virtual Investor Update on September 15, 2022, at 8:30 a.m. Eastern. The event will feature company leaders discussing Humana's strategic direction, operational and financial progress, and future performance expectations.
Participants can access the webcast through Humana’s Investor Relations page. For those unable to attend, a replay will be available approximately four hours after the event.
Humana aims to enhance health and lower costs through integrated care solutions for its members.
AM Best has affirmed Humana Inc.'s (NYSE: HUM) Financial Strength Rating (FSR) of A- (Excellent) and Long-Term Issuer Credit Ratings (ICR) of 'a-' (Excellent) for most of its health and dental insurance subsidiaries. The ratings reflect adequate balance sheet strength and operating performance, although recent challenges have outpaced net income. Humana remains the second-largest Medicare Advantage insurer in the U.S. and has expanded its Medicaid presence. The outlook for these ratings is stable, with financial leverage expected to decrease to approximately 40% by year-end 2022.
Humana Inc. has completed the rebranding of its home health division, Kindred at Home, to CenterWell Home Health, now operational in over 350 locations across 38 states. This initiative is integral to integrating home health services into Humana's broader business model, aiming to enhance patient outcomes.
With the rollout of the CenterWell brand, Humana focuses on unifying its healthcare services, including home health, primary care, and pharmacy, to provide a seamless care experience for its members, improving overall health and reducing costs.
Humana Inc. has partnered with Mays Business School at Texas A&M University to host the 2022 Humana-Mays Healthcare Analytics Case Competition. The competition, which aims to enhance students' analytical skills in addressing real-world healthcare challenges, offers a total prize package of $80,000 for winning teams. Eligible participants include graduate students from accredited U.S. institutions, competing in teams of 2 to 4. Key dates include registration opening on August 1, with finals announced on November 10.
CenterWell Senior Primary Care is set to launch nine new primary care centers aimed at seniors in the Phoenix area by early 2023. This expansion marks CenterWell's entry into the Arizona market, enhancing access to personalized healthcare services for local seniors. The initiative is part of a larger growth strategy, with plans to open up to 100 additional centers by 2025. Each location will provide care from board-certified professionals, emphasizing a holistic approach to patient health.
Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.7875 per share, payable on October 28, 2022, to stockholders of record as of the close of business on September 30, 2022. This dividend reflects Humana's commitment to returning value to its shareholders while supporting integrated care delivery to enhance health outcomes for its members, including those in Medicare and military service personnel. The company aims to lower healthcare costs and improve the quality of life for its diverse membership.
Humana Inc. (NYSE: HUM) announced its acquisition of Inclusa, Inc., a Managed Care Organization in Wisconsin, enhancing its long-term care service offerings. This acquisition is aimed at supporting approximately 16,600 older adults and adults with disabilities through Wisconsin's Family Care program. Inclusa has been connecting members with essential services for over 20 years and collaborates with over 6,000 service providers. The transaction, which is subject to regulatory approval, follows Humana's previous acquisition of iCare in 2020 and aims to increase its Medicaid membership, currently around 1 million across five states.
Humana Inc. (NYSE: HUM) has successfully completed its transaction with Clayton, Dubilier & Rice to divest a majority interest in the Hospice and Personal Care divisions of its subsidiary, Kindred at Home. The restructured divisions operate as a new standalone company, ensuring continued commitment to patient-centered care. Humana retains a minority ownership and strategic partnership to support these operations. The new entity, Gentiva, aims to enhance access and quality of care for patients while remaining an attractive employer for health professionals.